- multiple dose studies Loky do 2024-03-04 10:27
- multiple dose studies dshah 2024-03-08 17:36
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studies dshah 2024-03-12 17:37
- multiple dose studies Loky do 2024-03-11 11:20
- multiple dose studies dshah 2024-03-08 17:36
- crossover design when use RSABE with two test products Darborn 2023-08-22 02:24
- RSABE with two test products Helmut 2023-08-23 10:01
- RSABE with two test products Darborn 2023-08-23 11:13
- RSABE with two test products: Sample size? Helmut 2023-08-23 11:51
- RSABE with two test products: Sample size? Darborn 2023-08-30 08:07
- RSABE with two test products: Sample size? Helmut 2023-08-23 11:51
- RSABE with two test products fethiye 2024-02-23 07:14
- RSABE with two test products Darborn 2023-08-23 11:13
- crossover design when use ABEL with two test products BEQool 2024-02-22 09:15
- crossover design when use ABEL with two test products Helmut 2024-02-23 09:25
- crossover design when use ABEL with two test products BEQool 2024-02-25 09:59
- crossover design when use ABEL with two test products Helmut 2024-02-23 09:25
- RSABE with two test products Helmut 2023-08-23 10:01
- Steady state BE study dosing NK 2024-01-19 04:24
- Circadian rhythm? Helmut 2024-01-20 12:50
- Steady state BE study dosing dshah 2024-01-22 10:09
- AUC in steady state Helmut 2024-01-27 22:01
- AUC in steady state dshah 2024-01-27 22:06
- AUC in steady state Helmut 2024-01-27 22:16
- AUC in steady state dshah 2024-01-27 22:06
- AUC in steady state Helmut 2024-01-27 22:01
- Statistical Method and acceptance Vismayi 2024-01-23 09:29
- Mizolastine study design Bebac user 2023-12-20 18:47
- Single-dose study in patients Brus 2023-12-09 17:45
- Single-dose study in patients Helmut 2023-12-10 09:43
- Single-dose study in patients dshah 2023-12-11 10:44
- Amlodipine/Valsartan Bebac user 2023-09-09 06:34
- Amlodipine/Valsartan Helmut 2023-09-12 06:48
- Amlodipine/Valsartan Kumarnaidu2 2023-12-06 09:36
- Amlodipine/Valsartan dshah 2023-12-06 16:49
- Amlodipine/Valsartan Kumarnaidu2 2023-12-07 02:42
- Use all data and avoid the partial replicate design for the FDA Helmut 2023-12-07 09:01
- Amlodipine/Valsartan dshah 2023-12-06 16:49
- Amlodipine/Valsartan Kumarnaidu2 2023-12-06 09:36
- Amlodipine/Valsartan Helmut 2023-09-12 06:48
- Ebastine study design Bebac user 2023-11-25 13:07
- Ebastine study design dshah 2023-11-27 09:53
- Adhesion Score Analysis durga09 2023-07-17 11:15
- Stabilization period Vismayi 2023-06-26 19:55
- Stabilization period dshah 2023-06-27 08:46
- Stabilization period Achievwin 2023-06-30 15:13
- SD crossover study with no washout any examples Achievwin 2023-06-19 16:37
- SD crossover study with no washout any examples wienui 2023-06-20 06:00
- SD crossover study with no washout any examples Achievwin 2023-06-20 14:48
- SD crossover study with no washout any examples wienui 2023-06-20 06:00
- Switchability with replicate design studies Achievwin 2022-05-20 04:44
- Switchability = IBE Helmut 2022-05-20 09:17
- Switchability = IBE Achievwin 2022-05-20 14:19
- S × F interaction Helmut 2022-05-20 15:33
- S × F interaction Achievwin 2022-05-20 23:32
- S × F interaction Brus 2023-06-06 11:02
- S × F interaction Helmut 2023-06-07 10:34
- S × F interaction Achievwin 2023-06-08 10:21
- S × F interaction Helmut 2023-06-07 10:34
- S × F interaction Helmut 2022-05-20 15:33
- Switchability = IBE Achievwin 2022-05-20 14:19
- Switchability = IBE Helmut 2022-05-20 09:17
- Washout based on mean ± SD of t½ Imph 2022-09-25 13:52
- Washout based on mean ± SD of t½ Helmut 2022-09-25 16:08
- Washout based on mean ± SD of t½ Imph 2022-09-26 15:24
- Washout based on mean ± SD of t½ Shuanghe 2022-09-26 17:34
- Washout based on mean ± SD of t½ Helmut 2022-09-26 17:35
- If you have data… Helmut 2022-09-27 11:52
- If you have data… Imph 2022-10-25 09:21
- Washout based on mean ± SD of t½ Imph 2023-05-26 23:31
- Washout based on mean ± SD of t½ Helmut 2023-05-27 06:52
- Washout based on mean ± SD of t½ Imph 2023-05-27 08:36
- Washout based on mean ± SD of t½ Helmut 2023-05-27 06:52
- Washout based on mean ± SD of t½ Imph 2022-09-26 15:24
- Washout based on mean ± SD of t½ Helmut 2022-09-25 16:08
- Inclusion criteria in BE studies Loky do 2020-05-22 18:16
- BE: ♀♂ Helmut 2020-05-23 17:12
- Inclusion criteria in BE studies jag009 2020-05-25 07:43
- Stratify for sex? Helmut 2020-05-25 12:48
- Stratify for sex? jag009 2020-05-25 21:10
- Stratify for sex? Helmut 2020-05-25 12:48
- Inclusion criteria in BE studies ElMaestro 2020-05-25 14:39
- Inclusion criteria in BE studies Loky do 2020-06-10 13:19
- Inclusion criteria in BE studies BEQool 2023-05-05 10:42
- Sex-by-treatment interaction Helmut 2023-05-05 12:44
- Sex-by-treatment interaction BEQool 2023-05-11 09:12
- Sex-by-treatment interaction Helmut 2023-05-05 12:44
- Definition of Full Replicate Sereng 2023-03-13 17:08
- Definition of Full Replicate Mahmoud 2023-03-13 20:27
- Definition of Full Replicate Sereng 2023-03-13 23:38
- Definition of Full Replicate Mahmoud 2023-03-14 08:44
- Definition of Full Replicate Achievwin 2023-03-27 19:08
- Full Replicate with 3 periods mittyri 2023-03-27 22:16
- Full Replicate with 3 periods Achievwin 2023-03-28 03:06
- Full Replicate with 3 periods Helmut 2023-03-28 09:03
- Full Replicate with 3 periods mittyri 2023-03-27 22:16
- Definition of Full Replicate Achievwin 2023-03-27 19:08
- Definition of Full Replicate Mahmoud 2023-03-14 08:44
- Definition of Full Replicate Sereng 2023-03-13 23:38
- Definition of Full Replicate Brus 2023-03-14 10:10
- Replicate Design ≠ Higher-Order Crossover Helmut 2023-03-14 10:37
- Thank You! Sereng 2023-03-14 20:08
- Replicate Design ≠ Higher-Order Crossover Relaxation 2023-03-20 08:56
- imbalance in Latin Square mittyri 2023-03-27 23:01
- Balance for all effects Helmut 2023-04-21 10:01
- Definition of Full Replicate Mahmoud 2023-03-13 20:27